Literature DB >> 10952679

Effect of genistein on native epithelial tissue from normal individuals and CF patients and on ion channels expressed in Xenopus oocytes.

M Mall1, A Wissner, H H Seydewitz, M Hübner, J Kuehr, M Brandis, R Greger, K Kunzelmann.   

Abstract

The flavonoid genistein has been shown to activate a Cl(-) conductance in various cell types expressing CFTR. We examined if similar effects can be observed when genistein is applied to native ex vivo tissues from human respiratory tract and rectum. We further compared the effects when genistein was applied to oocytes of Xenopus laevis expressing CFTR. In oocytes, both wtCFTR and DeltaF508-CFTR were activated by genistein while both cyclic AMP (K(v)LQT1) and Ca(2+) (SK4) activated K(+) channels were inhibited at high concentrations of genistein. Biopsies from nasal polyps and rectal mucosa were obtained from normal individuals (non-CF) and CF patients and in the presence of amiloride (10 micromol l(-1); mucosal side) the effects of genistein were assessed using a perfused Ussing chamber. In non-CF airway epithelia, genistein (50 micromol l(-1); mucosal side) increased lumen negative I(sc) but had no additional effects on tissues pre-stimulated with IBMX and forskolin (100 micromol l(-1) and 1 micromol l(-1); both sides). In non-CF rectal biopsies, in the presence of amiloride (10 micromol l(-1); mucosal side) and indomethacin (10 micromol l(-1); basolateral side), genistein increased lumen negative I(sc) and enabled cholinergic (carbachol; CCH, 100 micromol l(-1); basolateral side) stimulation of Cl(-) secretion indicating activation of luminal CFTR Cl(-) channels. However, after stimulation with IBMX/forskolin, genistein induced opposite effects and significantly inhibited CCH activated I(sc). In CF airway and intestinal tissues genistein failed to induce Cl(-) secretion. Thus, genistein is able to activate luminal CFTR Cl(-) conductance in non-CF tissues and mutant CFTR in oocytes. However, additional inhibitory effects on basolateral K(+) conductance and missing effects in native CF tissues do not support the use for pharmacological intervention in CF.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952679      PMCID: PMC1572276          DOI: 10.1038/sj.bjp.0703520

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

1.  Failure of cholinergic stimulation to induce a secretory response from the rectal mucosa in cystic fibrosis.

Authors:  J Hardcastle; P T Hardcastle; C J Taylor; J Goldhill
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  The pharmacology of hSK1 Ca2+-activated K+ channels expressed in mammalian cell lines.

Authors:  M Shah; D G Haylett
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

3.  Ion transport abnormalities in rectal suction biopsies from children with cystic fibrosis.

Authors:  H J Veeze; M Sinaasappel; J Bijman; J Bouquet; H R de Jonge
Journal:  Gastroenterology       Date:  1991-08       Impact factor: 22.682

4.  Cholinergic ion secretion in human colon requires coactivation by cAMP.

Authors:  M Mall; M Bleich; M Schürlein; J Kühr; H H Seydewitz; M Brandis; R Greger; K Kunzelmann
Journal:  Am J Physiol       Date:  1998-12

5.  Genistein and tyrphostin 47 stimulate CFTR-mediated Cl- secretion in T84 cell monolayers.

Authors:  C L Sears; F Firoozmand; A Mellander; F G Chambers; I G Eromar; A G Bot; B Scholte; H R De Jonge; M Donowitz
Journal:  Am J Physiol       Date:  1995-12

6.  Role for tyrosine kinases in carbachol-regulated Ca entry into colonic epithelial cells.

Authors:  G Bischof; B Illek; W W Reenstra; T E Machen
Journal:  Am J Physiol       Date:  1995-01

7.  Mutations in the putative pore-forming domain of CFTR do not change anion selectivity of the cAMP activated Cl- conductance.

Authors:  A Hipper; M Mall; R Greger; K Kunzelmann
Journal:  FEBS Lett       Date:  1995-11-06       Impact factor: 4.124

8.  Forskolin increases cAMP and inhibits progesterone induced meiosis reinitiation in Xenopus laevis oocytes.

Authors:  S Schorderet-Slatkine; E E Baulieu
Journal:  Endocrinology       Date:  1982-10       Impact factor: 4.736

9.  Evidence for reduced Cl- and increased Na+ permeability in cystic fibrosis human primary cell cultures.

Authors:  R C Boucher; C U Cotton; J T Gatzy; M R Knowles; J R Yankaskas
Journal:  J Physiol       Date:  1988-11       Impact factor: 5.182

10.  cAMP-independent activation of CFTR Cl channels by the tyrosine kinase inhibitor genistein.

Authors:  B Illek; H Fischer; G F Santos; J H Widdicombe; T E Machen; W W Reenstra
Journal:  Am J Physiol       Date:  1995-04
View more
  13 in total

1.  Homozygous CFTR mutation M348K in a boy with respiratory symptoms and failure to thrive. Disease-causing mutation or benign alteration?

Authors:  Julia Hentschel; Gabriele Riesener; Heike Nelle; Manfred Stuhrmann; Anja Schöner; Olaf Sommerburg; Eva Fritzsching; Marcus A Mall; Ferdinand von Eggeling; Jochen G Mainz
Journal:  Eur J Pediatr       Date:  2012-01-25       Impact factor: 3.183

2.  Loss of carbonic anhydrase XII function in individuals with elevated sweat chloride concentration and pulmonary airway disease.

Authors:  Melissa Lee; Briana Vecchio-Pagán; Neeraj Sharma; Abdul Waheed; Xiaopeng Li; Karen S Raraigh; Sarah Robbins; Sangwoo T Han; Arianna L Franca; Matthew J Pellicore; Taylor A Evans; Kristin M Arcara; Hien Nguyen; Shan Luan; Deborah Belchis; Jozef Hertecant; Joseph Zabner; William S Sly; Garry R Cutting
Journal:  Hum Mol Genet       Date:  2016-02-23       Impact factor: 6.150

3.  Stimulation of murine intestinal secretion by daily genistein injections: gender-dependent differences.

Authors:  Layla Al-Nakkash; Lyn Batia; Minoti Bhakta; Amity Peterson; Nathan Hale; Ryan Skinner; Steven Sears; Jesse Jensen
Journal:  Cell Physiol Biochem       Date:  2011-08-16

4.  Activation of the cystic fibrosis transmembrane conductance regulator by the flavonoid quercetin: potential use as a biomarker of ΔF508 cystic fibrosis transmembrane conductance regulator rescue.

Authors:  Louise C Pyle; Jennifer C Fulton; Peter A Sloane; Kyle Backer; Marina Mazur; Jeevan Prasain; Stephen Barnes; J P Clancy; Steven M Rowe
Journal:  Am J Respir Cell Mol Biol       Date:  2009-12-30       Impact factor: 6.914

5.  Comparison of cystic fibrosis transmembrane conductance regulator (CFTR) and ciliary beat frequency activation by the CFTR Modulators Genistein, VRT-532, and UCCF-152 in primary sinonasal epithelial cultures.

Authors:  Bryant T Conger; Shaoyan Zhang; Daniel Skinner; Stephen B Hicks; Eric J Sorscher; Steven M Rowe; Bradford A Woodworth
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2013-08-01       Impact factor: 6.223

6.  CFTR is activated through stimulation of purinergic P2Y2 receptors.

Authors:  Diana Faria; Rainer Schreiber; Karl Kunzelmann
Journal:  Pflugers Arch       Date:  2008-11-12       Impact factor: 3.657

7.  The K+ channel opener 1-EBIO potentiates residual function of mutant CFTR in rectal biopsies from cystic fibrosis patients.

Authors:  Eva K Roth; Stephanie Hirtz; Julia Duerr; Daniel Wenning; Irmgard Eichler; Hans H Seydewitz; Margarida D Amaral; Marcus A Mall
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

8.  Genistein stimulates jejunum chloride secretion via an Akt-mediated pathway in intact female mice.

Authors:  Lana Leung; Ashesh Bhakta; Katherine Cotangco; Layla Al-Nakkash
Journal:  Cell Physiol Biochem       Date:  2015-02-12

Review 9.  Potential of Intestinal Current Measurement for Personalized Treatment of Patients with Cystic Fibrosis.

Authors:  Simon Y Graeber; Constanze Vitzthum; Marcus A Mall
Journal:  J Pers Med       Date:  2021-05-08

10.  Correction of G551D-CFTR transport defect in epithelial monolayers by genistein but not by CPX or MPB-07.

Authors:  Olga Zegarra-Moran; Leila Romio; Chiara Folli; Emanuela Caci; Frederic Becq; Jean-Michel Vierfond; Yvette Mettey; Giulio Cabrini; Pascale Fanen; Luis J V Galietta
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.